Merck Announces Results From Phase 3 Studies of ZEPATIER™ in Chronic Hepatitis C Patient...
Merck, known as MSD outside of the United States and Canada, today announced the presentation...
First-in-Human Clinical Trial for New Molecular Targeting Drug, Co-Developed with The University of Tokyo...
The National Cancer Center, The University of Tokyo, and Daiichi Sankyo Company, Limited announced a...
Results from Phase 3 Trial of Defibrotide for the Treatment of Severe Veno-Occlusive Disease...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that data from the phase 3 pivotal study...
clinical trials are critical for determining the safety and efficacy of new medicines and...
Roche is committed to sharing data from clinical trials and has registered and posted summary...
Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab...
Primary Endpoint Met in Study of Postmenopausal Women With Osteoporosis Transitioning From Bisphosphonate Treatment ...
Immunotherapy Atezolizumab Shrank Tumors in People with a Specific Type of Lung Cancer
Genentech will discuss results with the U.S. Food and Drug Administration (FDA) as part of...
AstraZeneca establishes Scientific Review Board to support clinical trial data transparency commitment
AstraZeneca today announced the creation of a Scientific Review Board that will act independently to...
UCB clinical trials policy
UCB is committed to providing the opportunity to patients to make informed decisions about participating...
clinical trials are critical for determining the safety and efficacy of new medicines and...
Roche is committed to sharing data from clinical trials and has registered and posted summary...
Disclosure Policy of the Astellas Group for Information on Conduct and Results of Clinical...
The Astellas Group (*1) (hereinafter collectively “Astellas”) recognises that making clinical trial information and results...
